PARLIAMENTARY DEBATES - United Kingdom Parliament

1081W
Written Answers
26 MARCH 2013
Written Answers
1082W
Anna Soubry: From 1 April 2013 this will be a matter
for the NHS Commissioning Board. As set out in the
NHS Mandate, the NHS Commissioning Board’s objective
is to uphold the NHS Constitution rights and commitments,
and where possible to improve the levels of performance
in access to care.
Breast Cancer: Brigg
Andrew Percy: To ask the Secretary of State for
Health how many and what proportion of women in
Brigg and Goole constituency with suspected breast
cancer saw a specialist within two weeks in each of the
last five years. [150156]
Anna Soubry: The information is not available in the
format requested. The number of patients urgently
referred by their general practitioner for suspected breast
cancer, and the number and percentage seen within two
weeks, at North Lincolnshire and Goole Hospitals NHS
Foundation Trust and Hull and East Yorkshire Hospitals
NHS Trust since Q4 2008-09 is shown in the following
tables:
Period
North Lincolnshire and Goole Hospitals NHS Foundation Trust
Total number of
patients
Number seen by
a specialist
within two weeks
Percentage seen
within two weeks
2008-09
Q4 318 316 99.4
2009-10
Q1 345 344 99.7
Q2 295 290 98.3
Q3 345 326 94.5
Q4 403 397 98.5
2010-11
Q1 401 396 98.8
Q2 390 384 98.5
Q3 371 369 99.5
Q4 370 366 98.9.
2011-12
Q1 342 339 99.1
Q2 347 346 99.7
Q3 321 317 98.8
Q4 405 402 99.3
2012-13
Q1 367 366 99.7
Q2 334 332 99.4
Q3 442 433 98.0
Source:
Department of Health, Cancer Waiting Times Database
Period
Hull and East Yorkshire Hospitals NHS Trust
Total number of
patients
Number seen by
a specialist
within two weeks
Percentage seen
within two weeks
2008-09
Q4 347 326 93.9
2009-10
Q1 346 329 95.1
Q2 406 383 94.3
Q3 361 347 96.1
Q4 370 362 97.8
2010-11
Q1 417 406 97.4
Q2 376 366 97.3
Q3 354 341 96.3
Q4 402 391 97.3
2011-12
Q1 406 396 97.5
Q2 367 362 98.6
Q3 426 419 98.4
Q4 381 374 98.2
2012-13
Q1 410 396 96.6
Q2 392 380 96.9
Q3 459 443 96.5
Notes:
1. From 1 January 2009 onwards the definitions and methodology used to
calculate these statistics are no longer directly comparable to those used
previously. This change means the NHS no longer adjusts the statistics to
account for patient choice, where individuals elect to delay their care.
2. All statistics are provider based, and may include patients whose care was
commissioned by the Welsh NHS. Statistics in this format were published for
the first time from Q4 2008-09.
Source:
Department of Health, Cancer Waiting Times Database
Cancer: Drugs
Sarah Newton: To ask the Secretary of State for
Health what estimate he has made of the number of
people in each strategic health authority area who have
received treatment through the Cancer Drugs Fund to
date. [150134]
Norman Lamb: Information on the number of patients
who have had cancer drugs funded by strategic health
authority (SHA) under the interim cancer drugs funding
arrangements in 2010-11 (from October 2010 to the end
of March 2011) and under the Cancer Drugs Fund
(from April 2011 to the end of January 2013) is shown
in the following table:
Strategic health authority
Number of patients funded
in 2010-11
Number of patients funded
in 2011-12
Number of patients funded
from April 2012 to end
January 2013
Total number of patients
funded since October 2010 1
North East 420 696 419 1,535
North West 266 1,044 1,527 2,837
Yorkshire and the Humber 178 809 1,169 2,156
East Midlands 178 871 797 1,846
West Midlands 292 1,658 1,278 3,228
East of England 246 1,486 1,413 3,145
London 443 1,364 1,529 3,336